50 new BIA members in first part of 2008
A total of 50 companies have joined the UK's BioIndustry Association during the year ended August 31, the BIA reported at its annual general meeting. These include corporate members developing new medicines and technologies as well as associates providing services to the sector.
Of the new member firms, 21 have joined the BIA's Fledgling Club, which was launched last year (Marketletter October 12, 2007). This now has 28 members, and offers a range of services specifically tailored to the needs of a growing company and was established to support and assist emerging enterprises to grow and develop into the UK success stories of tomorrow.
Aisling Burnand, BIA chief executive, said: "the last year has been a challenging one for the bioscience sector in the UK and I am delighted that more companies are recognising the benefit of the collective voice that the BIA provides for its members. And I am particularly pleased to see that our Fledgling Club, launched at last year's AGM, is proving to be such a success."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze